MediSpan
Latest round
- Series A
Last raised
- May 2021
Total raised
- $5.8M
Investors
- 3
About MediSpan
Founded in 2020 and based in Seongnam, South Korea, MediSpan operates as a biotechnology company that develops immunotherapies for anti-aging. The company creates medications and therapies for age-related illnesses like inflammatory growth disorders, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, and infectious diseases. The business offers immunotherapies that support aging improvement and the treatment of geriatric diseases using its patented processes, allowing patients to experience improved aging and healthy life extension.
Who invested in MediSpan
3 investors across 1 round
See all investors in MediSpan
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 13, 2021
Amount
$5.8M
Investors
Questions about MediSpan
Who invested in MediSpan?
MediSpan has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MediSpan raised?
MediSpan has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MediSpan last raise money?
MediSpan's most recent round on record is a Series A, in May 2021.
What does MediSpan do?
Founded in 2020 and based in Seongnam, South Korea, MediSpan operates as a biotechnology company that develops immunotherapies for anti-aging.
Where is MediSpan headquartered?
MediSpan is headquartered in Seongnam, South Korea.
Which VCs invest in companies like MediSpan?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at MediSpan's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like MediSpan? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.